Posted by Michael Wonder on 15 May 2026
Wegovy and Mounjaro for weight loss not funded
14 May 2026 - PHARMAC has assessed the application to fund Wegovy for weight loss and added it to our Options for Investment List.
The Obesity Treatment Advisory Group considered an application to fund semaglutide (Wegovy) in December 2025.
